Your browser doesn't support javascript.
loading
Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.
Zhou, Zilan; Jafari, Mina; Sriram, Vishnu; Kim, Jinsoo; Lee, Joo-Youp; Ruiz-Torres, Sasha J; Waltz, Susan E.
Afiliación
  • Zhou Z; Chemical Engineering Program, Department of Chemical and Environmental Engineering, University of Cincinnati , Cincinnati, Ohio 45221-0012, United States.
  • Jafari M; Chemical Engineering Program, Department of Chemical and Environmental Engineering, University of Cincinnati , Cincinnati, Ohio 45221-0012, United States.
  • Sriram V; Chemical Engineering Program, Department of Chemical and Environmental Engineering, University of Cincinnati , Cincinnati, Ohio 45221-0012, United States.
  • Kim J; Chemical Engineering Program, Department of Chemical and Environmental Engineering, University of Cincinnati , Cincinnati, Ohio 45221-0012, United States.
  • Lee JY; Chemical Engineering Program, Department of Chemical and Environmental Engineering, University of Cincinnati , Cincinnati, Ohio 45221-0012, United States.
  • Ruiz-Torres SJ; Department of Cancer Biology, College of Medicine University of Cincinnati , Cincinnati, Ohio 45267-0521, United States.
  • Waltz SE; Department of Cancer Biology, College of Medicine University of Cincinnati , Cincinnati, Ohio 45267-0521, United States.
Mol Pharm ; 14(12): 4551-4559, 2017 12 04.
Article en En | MEDLINE | ID: mdl-29077410

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Nanocápsulas / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Nanocápsulas / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos